OBINOTUZUMAB Versus Cyclophosphamide + Glucocorticoids in Primary Membranous Nephropathy(Blossom Study)

Clinical trial NCT06781944 · RECRUITING

Trial details

NCT number: NCT06781944
Sponsor: Huashan Hospital
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Membranous Nephropathy

Start date: 2024-10-23
Primary completion: 2028-05-31
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.